T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNET
776
DELISTED
RigNet, Inc.
RNET
| $64.6M | 0.01% |
1,201,124
-888,594
| -43% | -$44.5M |
|
777
Luxfer Holdings
LXFR
$457M
| $64.6M | 0.01% |
3,408,511
+480,921
| +16% | +$9.22M |
|
778
Alcoa
AA
$13.1B
| $64.4M | 0.01% |
1,799,062
-170,129
| -9% | -$5.58M |
|
|
SWC
779
DELISTED
Stillwater Mining Co
SWC
| $64.2M | 0.01% |
3,656,156
-446,501
| -11% | -$7.26M |
|
780
Cavco Industries
CVCO
$4.67B
| $64.2M | 0.01% |
752,110
+4,100
| +0.5% | +$319K |
|
|
SPTN
781
DELISTED
SpartanNash
SPTN
| $63.6M | 0.01% |
3,028,950
+129,100
| +4% | +$2.87M |
|
782
Teradyne
TER
$64.2B
| $63.6M | 0.01% |
3,244,314
+45,200
| +1% | +$841K |
|
|
ASCMA
783
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $63.5M | 0.01% |
961,655
+2,615
| +0.3% | +$174K |
|
784
Myers Industries
MYE
$1.25B
| $63.5M | 0.01% |
3,159,375
-21,520
| -0.7% | -$449K |
|
785
HEICO Corp Class A
HEI.A
$38.1B
| $63.4M | 0.01% |
3,810,376
-1,464,600
| -28% | -$24.6M |
|
786
Wolfspeed
WOLF
$1.64B
| $63.3M | 0.01% |
1,267,848
-397,887
| -24% | -$19.8M |
|
787
Fortinet
FTNT
$121B
| $63.2M | 0.01% |
12,581,500
-812,400
| -6% | -$3.64M |
|
788
PVH
PVH
$3.77B
| $63.2M | 0.01% |
541,863
-812,239
| -60% | -$101M |
|
789
Eversource Energy
ES
$27.2B
| $63M | 0.01% |
1,332,694
-27,510
| -2% | -$1.26M |
|
790
FMC
FMC
$1.27B
| $62.9M | 0.01% |
1,018,011
-4,077,983
| -80% | -$267M |
|
791
American Eagle Outfitters
AEO
$2.73B
| $62.7M | 0.01% |
5,591,130
+2,491,060
| +80% | +$28.3M |
|
792
Hexcel
HXL
$7.74B
| $62.6M | 0.01% |
1,531,370
-183,540
| -11% | -$7.64M |
|
|
PGI
793
DELISTED
PREMIERE GLOBAL SERVICES, INC.
PGI
| $61.8M | 0.01% |
4,632,590
-822,210
| -15% | -$10.5M |
|
794
Whirlpool
WHR
$2.79B
| $61.8M | 0.01% |
444,030
-65,490
| -13% | -$9.61M |
|
|
CTRX
795
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $61.7M | 0.01% |
1,396,207
-1,295,665
| -48% | -$54.8M |
|
796
General Dynamics
GD
$106B
| $61.1M | 0.01% |
524,514
+10,990
| +2% | +$1.25M |
|
|
SMRT
797
DELISTED
Stein Mart Inc
SMRT
| $61.1M | 0.01% |
4,400,310
+10,700
| +0.2% | +$142K |
|
|
DEL
798
DELISTED
Deltic Timber
DEL
| $61.1M | 0.01% |
1,010,730
+18,266
| +2% | +$1.12M |
|
799
Ambev
ABEV
$43.8B
| $60.8M | 0.01% |
8,635,700
-1,362,800
| -14% | -$10M |
|
800
Advanced Energy
AEIS
$13.2B
| $60.7M | 0.01% |
3,155,780
+181,080
| +6% | +$3.7M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.